Current Issue
VOL 13 NO 7 • Sep/Oct 2022
This issue’s cover illustration depicts the sagittal section through orbit showing intraocular cancer. A light-colored iris demonstrates color change along with a tumor arising from the melanocytes present in the lining of the retina. The background shows the tebentafusp-tebn mechanism of action as a drug molecule redirects T cells (on right) to target gp100-expressing uveal melanoma tumor cells (on left). Artwork by Alexandra Webber Baker © 2022, DNA Illustrations, Inc., Asheville, North Carolina.EditorialBeth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPOWriting for publication allows one to share ideas, thoughts, research, and practice patterns. A valuable tool to disseminate various types of information, peer-reviewed articles contribute to the body of literature and collective knowledge. As Editor-in-Chief of JADPRO, I receive many questions f...
Research and ScholarshipFedricker D. Barber (1), Erick Campbell (1), Yuko Yamamura (1), Clover J. Patterson (1), Audrey C. Hartnett (1), Holly Kinahan (1), Victoria A. Miller (1), Amanda L. Brink (1), Anna Poullard (1), Gabriele E. Urschel (1), Andre Brantley (1), Isabel G. Cepeda (1), Poonam Goswami (1), Sheena Charles (1), Shincy Philip (1), Sara Bresser (1), Sandra Musekiwa-Adjei (1), Nageli Perez (1), Hung Le (1), Penny Phillips (2), Vivek Subbiah (1), Funda Meric-Bernstam (1,3,4), and Ecaterina E. Dumbrava (1)The process of clinical drug development classically has to follow three phases before regulatory (US Food and Drug Administration or European Medicines Agency) approval; however, there have been exceptions in which drugs were approved for tumor location–agnostic indications in the presence of co...
Research and ScholarshipDenisse Mae Trinidad, PharmD, and Puja R. Patel, PharmD, BCOPThe Centers for Disease Control and Prevention and the US Surgeon General both acknowledge that increasing demands for access, safety, quality, and cost in the health-care system in the United States is a challenge, and that patient care services delivered by pharmacists can significantly contrib...
Review ArticleWhitney Randolph, APRN, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANPRadiation, either alone or with chemotherapy, is the recommended front-line treatment for many adult head and neck cancer (HNC) patients and has improved overall survival (National Comprehensive Cancer Network, 2021; Pulte & Brenner, 2010). Critical vascular structures, including the carotid ...
Review ArticleElizabeth Hubert, APRN, FNP-C, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANPAmyloidosis refers to a family of diseases characterized by extracellular amyloid fibril deposition. Amyloid deposits result in significant dysfunction within the affected organs and soft tissues. The subtypes of amyloidosis most frequently encountered in clinical practice include light chain (AL...
Grand RoundsAshley Martinez,(1) DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, Tiffany Jones,(2) MSN, ACNP-BC, Joanne C. Ryan,(3) PhD, RN, Chad M. Barnett,(3) PharmD, BCOP, Elpitha L. Soussou,(3) PharmD, MBA, and Sarah Donahue,(4) MPH, NP, AOCNP®Case Study
Rozina is a 42-year-old premenopausal woman who presented to her primary care physician with worsening back pain over a few months that did not abate following physical therapy (Table 1). Her initial workup included an MRI of the thoracic spine that discovered a suspicious lesion at T6...
Practice MattersKatharine Lord,(1) PA-C, Sara Toth,(2) APRN, FNP-C, AOCNP®, AGN-BC, Jennifer Potter,(3) PA-C, Katherine Sellers,(4) PA-C, Monica White,(5) APRN, CNS-AH, ACNP-BC, AOCNP®, Anne Neugent,(4) APRN, FNP-C, and Tracy Martin,(4) APRN, ANP-C, AOCNP®, BMTCN, NursEdBone marrow aspiration and biopsy procedures are commonly used in oncology practice for the diagnosis and staging of hematologic/oncologic disease and evaluation of response to treatment. Trained providers, including advanced practice providers (APPs), perform this procedure in both inpatient and...
Prescriber's CornerGwen Hua,(1) PharmD, Daniel Carlson,(2) DO, and Jacqueline R. Starr,(1) PharmD, BCOPUveal melanoma is the most common intraocular cancer in adults, representing approximately 3% to 5% of all melanomas (Jager et al., 2020). The annual incidence of uveal melanoma in Europe and the US is approximately 6 cases per million population per year (Jager et al., 2020). The incidence of uv...
